News | May 24, 2025
Strides Pharma Q4 net profit rises 5x to Rs. 113 Cr
For the full year FY25, net profit soared 12x to Rs 345 crore
For the full year FY25, net profit soared 12x to Rs 345 crore
Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products
Scored 85/100, 2.3x the industry average in Social and 73/100, 1.8x the industry average in Governance
Dr. Muthu was last associated with Mankind Pharma
Strides Pharma Science has reported total income of Rs. 1,229.52 crores during the period ended September 30, 2024
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
The revenue for the Q1FY25 came in at Rs 1,085.7 crore, up 16.6 per cent YoY
AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka
Trinity has availed credit facility from Investec for Business for their working capital requirements of Rs. 31.5 crore
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
Subscribe To Our Newsletter & Stay Updated
